NIKINasdaqMeasuring & Controlling Devices, NECFiscal year ends December 31
Niki BioSolutions, Inc.
Financials through Q4 FY2025, quarter ended Dec 31, 2025Last filing: 20-F on Mar 27, 2026
$2.08+0.05 (+2.46%)
Close on Oct 19, 2026
- Market cap
- $16.66M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Who owns Niki BioSolutions's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| CGY Investments Limited (“ CGY Investments ”) (1) | 533,575 | – | 13D (active) amendment | Apr 8, 2024 |
| Kira S. Sheinerman | 1,515,293 | 51.56% | 13D (active) | Jul 20, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Alidad Mireskandari | President, & COO | – | – | Jul 28, 2026 |
| Justin Che Yuen Wu | Director | 1,832 | 0.02% | Aug 13, 2026 |
| Douglas Wayne Arner | Director | 1,062 | 0.01% | Aug 13, 2026 |
| Laura A. Philips | Director | 6,024 | 0.07% | Jul 24, 2026 |
| Kira Sheinerman | Director, 10% owner | 1,515,293 | 18.61% | Jul 24, 2026 |